FIELD: medicine. SUBSTANCE: this method prescribes administering dalargin in amount of 0.1 mg/kg for infarction therapy, determining peptide balance in human organism by paramecium test using dalargin. In case of deficiency of stress-limiting peptides, dalargin dose should be increased, and vice versa, decreased to 0.015 mg/kg. EFFECT: excellent results. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PROGNOSTICATING PROGRESS OF ISCHEMIC HEART DISEASE | 1989 |
|
RU2006039C1 |
METHOD OF LIMITATION OF DAMAGE ZONE AND REPARATIVE PROCESSES ACCELERATION AT MYOCARDIUM INFARCTION | 1991 |
|
RU2086979C1 |
METHOD FOR PROPHYLAXIS OF ANGINOUS PAIN RELAPSES AT MYOCARDIAL INFARCTION | 1993 |
|
RU2113856C1 |
ANTIARRYTHMIC AGENT | 1983 |
|
RU2068261C1 |
METHOD FOR REPRODUCING CARDIOGENIC SHOCK IN SMALL-SIZED LABORATORY ANIMALS | 2003 |
|
RU2239874C1 |
ANTIANGINAL AGENT | 2001 |
|
RU2200026C2 |
METHOD FOR DIAGNOSING AND PREVENTING FREQUENTLY OCCURRED HERPES SIMPLEX RECIDIVATION | 1997 |
|
RU2159632C2 |
METHOD FOR TREATING ARRHYTHMIC SYNDROME IN CASE OF PROGRESSING STENOCARDIA | 2004 |
|
RU2266130C1 |
METHOD FOR PERIOPERATIVE ORGAN PROTECTION IN PATIENTS WITH HEAD AND NECK TUMORS | 2023 |
|
RU2822968C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
Authors
Dates
1995-04-10—Published
1990-08-13—Filed